Retatrutide
Triple-receptor research compound. GLP-1 / GIP / glucagon pathway investigation.
RESTRICTED ACCESS
All products on this site are research chemicals sold strictly for laboratory and analytical purposes. Not for human or animal consumption. Confirm the following to enter.
I do not agree, exitMETABOLIC & GLP-1
Modified C-terminal HGH fragment (residues 177–191). Lipolysis-pathway research compound.
ABOUT THIS COMPOUND
AOD-9604 is a synthetic modified fragment of human growth hormone, corresponding to residues 177–191 of the parent molecule with an additional tyrosine residue. It is widely investigated for lipolysis and fat-metabolism pathway research.
The compound was originally developed by Metabolic Pharmaceuticals as a research candidate distinct from full-length growth hormone. Solid-phase synthesized in our U.S. facility and HPLC-verified per lot.
SPECIFICATIONS
RESEARCH APPLICATIONS
All applications are investigative. This compound is sold for research-use only and is not for human or animal consumption.
QUALITY ASSURANCE
A current-lot Certificate of Analysis is available for every compound. Email us with the product and lot number; we'll send the documentation. Read about our lab testing →
YOU MAY ALSO RESEARCH
QUESTIONS?
Lot questions, COA requests, institutional accounts, reach the team directly.
CONTACT US